Mercados/AccionesArticle

Oxford Biomedica reports 10% revenue growth in first half

Oxford Biomedica reported a 10% increase in revenue for the first half of the year.

PA

Priya Anand · Equities & Earnings Desk · 22 Sept 2026 · 07:14 · 1 min de lectura

Oxford Biomedica reports 10% revenue growth in first half

Oxford Biomedica reported a 10% increase in revenue for the first half of the year.

Further verified details were not immediately available.

Equities

Este artículo fue producido con asistencia de IA y editado por un periodista de Finance Review Daily.

Novara — A Smarter Way to Access Global Markets

Compartir esta noticia

PA

Escrito por

Priya Anand

Equities & Earnings Desk

Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.

Más de Priya Anand →

Panorama del mercado

Con retraso

EUR/USD1.1472▲ 0.07%GBP/USD1.3383▲ 0.10%USD/CHF0.8203▼ 0.10%BTC/USD85,576.2▼ 1.21%ETH/USD2,732.85▼ 1.56%XAU/USD4,336.95▼ 0.16%

Oxford Biomedica reports 10% revenue growth in first half

Panorama del mercado

Lecturas relacionadas

Frankfurt opens lower as oil surge and AI fears weigh on Europe's benchmark

Newron reports first-half loss amid Evenamide R&D surge

Swiss Market Slides as SMI Dips 0.16% Amid Mixed Sector Performance

U.S. Stock Futures Steady After AI Rally Lifts Wall St; China Summit in Focus

Seed Capital Solutions reports £92,600 loss, launches fundraising